Literature DB >> 23184053

Association of glutathione S-transferase P1 gene polymorphism with the histological types of lung cancer: a meta-analysis.

Xu Feng1, Hua-Fu Zhou, Bao-Shi Zheng, Jun-Jie Shi, Cheng Luo, Jia-Jin Qin.   

Abstract

The conclusions of the published reports on the relationship between glutathione S-transferase P1 (GSTP1) A/G gene polymorphism and the histological types of lung cancer are still debated. GSTP1 is one of the important mutant sites reported at present. This meta-analysis was performed to evaluate the association between GSTP1 and histological types of lung cancer. The association investigations were identified from PubMed and Cochrane Library, and eligible studies were included and synthesized using meta-analysis method. Seventeen reports were included into this meta-analysis for the association of GSTP1 A/G gene polymorphism and histological types of lung cancer. The G allele and GG genotype were not associated with the susceptibility of risk of squamous cell carcinomas, adenocarcinomas, small cell carcinoma, non-small cell carcinoma or large cell carcinoma. However, in the sub-group analysis, there was an association between G allele/GG genotype with the risk of squamous cell carcinomas in East-Asians and GG genotype was associated with the risk of small cell carcinoma in Caucasians. In conclusion, GSTP1 A/G gene polymorphism is not associated with the susceptibility of squamous cell carcinomas, adenocarcinomas, small cell carcinoma, non-small cell carcinoma or large cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184053     DOI: 10.1007/s11033-012-2324-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  32 in total

Review 1.  The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials.

Authors:  Yuan-Han Qin; Tian-Biao Zhou; Li-Na Su; Feng-Ying Lei; Yan-Jun Zhao; Wei-Fang Huang
Journal:  Blood Coagul Fibrinolysis       Date:  2010-12       Impact factor: 1.276

2.  Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer.

Authors:  N Jourenkova-Mironova; H Wikman; C Bouchardy; A Voho; P Dayer; S Benhamou; A Hirvonen
Journal:  Pharmacogenetics       Date:  1998-12

3.  Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas.

Authors:  A Risch; H Wikman; S Thiel; P Schmezer; L Edler; P Drings; H Dienemann; K Kayser; V Schulz; B Spiegelhalder; H Bartsch
Journal:  Pharmacogenetics       Date:  2001-12

4.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

5.  TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.

Authors:  Jing-Jun Wang; Yuan Zheng; Liang Sun; Li Wang; Peng-Bo Yu; Jian-Hua Dong; Lei Zhang; Jing Xu; Wei Shi; Yu-Chun Ren
Journal:  Mol Biol Rep       Date:  2010-12-08       Impact factor: 2.316

6.  Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers.

Authors:  M Kihara; M Kihara; K Noda
Journal:  Cancer Lett       Date:  1999-03-22       Impact factor: 8.679

7.  Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population.

Authors:  Geyu Liang; Yuepu Pu; Lihong Yin
Journal:  Cancer Lett       Date:  2005-06-08       Impact factor: 8.679

8.  Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.

Authors:  Leelakumari Sreeja; Vani Syamala; Sreedharan Hariharan; Volga S Syamala; Praveenkumar B Raveendran; C D Sivanandan; Jayaprakash Madhavan; Ravindran Ankathil
Journal:  J Exp Ther Oncol       Date:  2008

9.  Combined effect of polymorphic GST genes on individual susceptibility to lung cancer.

Authors:  S T Saarikoski; A Voho; M Reinikainen; S Anttila; A Karjalainen; C Malaveille; H Vainio; K Husgafvel-Pursiainen; A Hirvonen
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

10.  Bioinformatics analysis reveals connection of squamous cell carcinoma and adenocarcinoma of the lung.

Authors:  Wei-Dong Fan; Xian-Quan Zhang; Hui-Lin Guo; Wei-Wei Zeng; Ni Zhang; Qian-Qian Wan; Wen-Yao Xie; Jin Cao; Chang-Hua Xu
Journal:  Asian Pac J Cancer Prev       Date:  2012
View more
  5 in total

1.  CYP1A1 MspI polymorphism and the risk of oral squamous cell carcinoma: Evidence from a meta-analysis.

Authors:  Shang Xie; Chongdai Luo; Xiaofeng Shan; Shushan Zhao; Jing He; Zhigang Cai
Journal:  Mol Clin Oncol       Date:  2016-02-05

2.  Genetic polymorphism of lysyl oxidase, glutathione S-transferase M1, glutathione-S-transferase T1, and glutathione S-transferase P1 genes as risk factors for lung cancer in Egyptian patients.

Authors:  Sahar E M El-Deek; Soad M Abdel-Ghany; Randa S Hana; Aliaa A R Mohamed; Naglaa T El-Melegy; Ayat A Sayed
Journal:  Mol Biol Rep       Date:  2021-05-30       Impact factor: 2.316

3.  Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on lung cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.

Authors:  Wen-Ping Zhang; Chen Yang; Ling-Jun Xu; Wei Wang; Liang Song; Xiao-Feng He
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

4.  Association between CYP1A1 Ile462Val Polymorphism and Oral Squamous Cell Carcinoma Susceptibility: Evidence from 13 Investigations.

Authors:  Xiao-Lei Yang; Shang Xie; Yi-Yan Jiang; Chang Shi; Zhi-Gang Cai; Su-Xiu Chen
Journal:  J Cancer       Date:  2015-01-22       Impact factor: 4.207

5.  Glutathione S-transferase pi 1 variant and squamous cell carcinoma susceptibility: a meta-analysis of 52 case-control studies.

Authors:  Shuang Wang; Jingqi Zhang; Fan Jun; Zhijie Bai
Journal:  BMC Med Genet       Date:  2019-01-21       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.